Global Clinical Development Lead — Internal Medicine

Pfizer; Pennsylvania; On-site; USD 215,000 - 358,000; Full time

Job summary

Pfizer is seeking a Global Development Lead to represent Clinical on the Global Medicine Team and serve as the single clinical point of accountability for development of assigned assets in Internal Medicine.

You will lead a cross‑functional Clinical Development Team across clinical, pharmacology, statistics, safety, commercial, patient access and operations in the design, execution and interpretation of studies for worldwide regulatory submissions.

Qualifications

• BS with 12 yrs or PhD with 7 yrs, relevant clinical/industry experience.
• Experience leading cardiometabolic late-stage development programs, including type 2 diabetes.
• Extensive knowledge of clinical development, global and regional regulation, ICH/GCP, adverse event management.
• Demonstrated ability to lead large teams and coordinate cross-functional trial teams.

Responsibilities

• Partner with Prod Team Lead to negotiate milestones and ensure delivery of the clinical program.
• Develop comprehensive clinical development plan to secure global approval and reimbursement, including pediatric plans.
• Provide input for target product profiles and regulatory activities.
• Lead regulatory submissions and contribute to submission deliverables.
• Engage external stakeholders to drive strategic insight for clinical development.

Skills

Leadership

Regulatory strategy

Project management

Communication

Cross-functional collaboration

Education

Bachelor's degree or PhD with clinical/industry experience

Job description

Pfizer is seeking a Global Development Lead to represent Clinical on the Global Medicine Team and serve as the single clinical point of accountability for development of assigned assets in Internal Medicine.

You will lead a cross‑functional Clinical Development Team across clinical, pharmacology, statistics, safety, commercial, patient access and operations in the design, execution and interpretation of studies for worldwide regulatory submissions.